Details for New Drug Application (NDA): 073630
✉ Email this page to a colleague
NDA 073630 describes SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, which is a drug marketed by Bausch And Lomb and Genus and is included in two NDAs. It is available from three suppliers. Additional details are available on the SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE profile page.
The generic ingredient in SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
The generic ingredient in SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
Summary for 073630
| Tradename: | SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE |
| Applicant: | Genus |
| Ingredient: | prednisolone sodium phosphate; sulfacetamide sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.23% PHOSPHATE;10% | ||||
| Approval Date: | May 27, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
